Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa

Rhea-AI Summary

Miromatrix Medical (NASDAQ: MIRO) announces CEO Jeff Ross will present at the 2022 Cell & Gene Meeting on the Mesa from October 11-13. This event showcases advancements in cell therapy, gene therapy, gene editing, and regenerative medicine. Ross's presentation is scheduled for October 12 at 6:30 pm ET. Miromatrix focuses on bioengineering fully transplantable human organs, primarily targeting liver and kidney development, utilizing a proprietary perfusion technology platform to combat organ shortages.

EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that CEO Jeff Ross will present at the 2022 Cell & Gene Meeting on the Mesa. The three day event held this year on October 11-13 features in-person and pre-recorded virtual presentations by leading public and private companies highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine.

Mr. Ross will deliver his remarks at the 2022 Cell & Gene Meeting on the Mesa in the Oxford Biomedica Ballroom on October 12^th, 2022 at 6:30 pm ET. Registration for the conference is available here.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

 

FAQ

When will Miromatrix CEO Jeff Ross present at the Cell & Gene Meeting on the Mesa?

Jeff Ross will present on October 12, 2022, at 6:30 pm ET.

What is the focus of Miromatrix Medical's bioengineering technology?

Miromatrix Medical focuses on bioengineering fully transplantable human organs, specifically targeting livers and kidneys.

What topics will be covered at the 2022 Cell & Gene Meeting on the Mesa?

The 2022 Cell & Gene Meeting will cover advancements in cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine.

Where can I register for the 2022 Cell & Gene Meeting on the Mesa?

Registration for the conference is available on the event's official website.

What is the ticker symbol for Miromatrix Medical?

The ticker symbol for Miromatrix Medical is MIRO.